J E Wolff

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. ncbi Dexamethasone increases hepatotoxicity of MTX in children with brain tumors
    J E Wolff
    Department of Pediatric Oncology, Alberta Children s Hospital, Calgary, Canada
    Anticancer Res 18:2895-9. 1998
  2. ncbi Long recovery times improve the detection of cellular resistance in vitro
    J E Wolff
    Department of Pediatric Oncology and Hematology, Westfalische Wilhelms University, Munster, Germany
    J Cancer Res Clin Oncol 124:409-14. 1998
  3. ncbi Mesna inactivates platinum agents in vitro
    J E Wolff
    Alberta Children s Hospital, Calgary, Canada
    Anticancer Res 18:4077-81. 1998
  4. ncbi Chemosensitivity of glioma cells in vitro: a meta analysis
    J E Wolff
    Department of Pediatric Oncology, University of Munster, Germany
    J Cancer Res Clin Oncol 125:481-6. 1999
  5. ncbi Falsification of tetrazolium dye (MTT) based cytotoxicity assay results due to mycoplasma contamination of cell cultures
    J Denecke
    University Hospital of Munster, Department of Pediatrics, Munster, Germany
    Anticancer Res 19:1245-8. 1999
  6. ncbi The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin
    A Oprea
    Cancer Biology Research Group, University of Calgary, Faculty of Medicine, Southern Alberta Cancer Research Centre, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada
    Anticancer Res 21:1225-9. 2001

Collaborators

Detail Information

Publications6

  1. ncbi Dexamethasone increases hepatotoxicity of MTX in children with brain tumors
    J E Wolff
    Department of Pediatric Oncology, Alberta Children s Hospital, Calgary, Canada
    Anticancer Res 18:2895-9. 1998
    ..As previously shown, dexamethasone can reduce the efficacy of methotrexate in vitro (Anticancer Res. 14: 1585-8). Consequently, DEX has been avoided during high dose methotrexate infusions in a pilot study...
  2. ncbi Long recovery times improve the detection of cellular resistance in vitro
    J E Wolff
    Department of Pediatric Oncology and Hematology, Westfalische Wilhelms University, Munster, Germany
    J Cancer Res Clin Oncol 124:409-14. 1998
    ..Experiments showing resistance after short recovery times are reliable, but lack of resistance can only be shown in experiments with long recovery times. Cisplatin treatment can result in resistance to radiation in glioma cells...
  3. ncbi Mesna inactivates platinum agents in vitro
    J E Wolff
    Alberta Children s Hospital, Calgary, Canada
    Anticancer Res 18:4077-81. 1998
    ..Platinum agents are frequently combined with ifosfamide. Mesna, originally coadministered to protect from ifosfamide side effects, might also react with the platinum agents in these combinations...
  4. ncbi Chemosensitivity of glioma cells in vitro: a meta analysis
    J E Wolff
    Department of Pediatric Oncology, University of Munster, Germany
    J Cancer Res Clin Oncol 125:481-6. 1999
    ..We compared the in vitro efficacy of chemotherapeutic agents, developing a method to summarize published data...
  5. ncbi Falsification of tetrazolium dye (MTT) based cytotoxicity assay results due to mycoplasma contamination of cell cultures
    J Denecke
    University Hospital of Munster, Department of Pediatrics, Munster, Germany
    Anticancer Res 19:1245-8. 1999
    ..Differences decreased with decreasing drug doses and decreasing plated cell count. Our findings confirm the compelling need for periodical mycoplasma screening, especially when tetrazolium based cytotoxicity assay (MTT) are used...
  6. ncbi The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin
    A Oprea
    Cancer Biology Research Group, University of Calgary, Faculty of Medicine, Southern Alberta Cancer Research Centre, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada
    Anticancer Res 21:1225-9. 2001
    ....